Delivery Order V797D30296-VA24817F0523
Award Date
3/1/17
Potential Completion Date
3/31/17
Potential Value
$243K
Federal Agency
Veterans Integrated Service Network 8
Awardee
Astellas Pharma US, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
112 Calle Arzuaga Ste 1, San Juan, 00925, Puerto Rico
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the pharmaceutical product XTANDI, awarded by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA) to Astellas Pharma US, Inc. The $243,162 firm fixed-price delivery order was placed under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The ultimate completion date is June 30, 2016. Astellas Pharma US, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that provides...
This is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Astellas Pharma US, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, under the VA's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The $76,788.00 firm-fixed-price contract is for the supply of the oncology medication enzalutamide (XTANDI) 40mg tablets in 120-count bottles, with a period of performance ending on September 30, 2015. Astellas has previously received...
This federal contract award is for the delivery of the pharmaceutical product ENZALUTAMIDE 40MG TAB 120/BT to the U.S. Department of Veterans Affairs (VA). The contract was awarded to the prime contractor Astellas Pharma US, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, as a delivery order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract has a potential ceiling value of $76,788.00 and was awarded on October 7, 2015, with a completion...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Astellas Pharma US, Inc., a foreign-owned for-profit pharmaceutical manufacturer. The $243,162.00 contract is for the provision of pharmaceuticals and drugs, with no set-aside designation, under the Pharmaceuticals and Drugs General Services Administration (GSA) Federal Supply Schedule (FSS) contract. Astellas has previously held other VA contracts and Blanket...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $4,169.59 order is for XTANDI 40 MG TABLET 120S and is part of a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program. This single-award IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the recurring medical supply needs...
This federal contract award is for the delivery of XTANDI 40 MG TABLET 120S to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense (DoD). The contract, valued at $4,169.59, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's larger indefinite delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,339.18 order is for 60 tablets of the prescription drug XTANDI 80 MG. The order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that allows the DLA to issue delivery orders for a wide range of pharmaceutical products to support the recurring medical...
This federal contract award is for the delivery of XTANDI 40 MG CAPSULE 120S to the U.S. Department of Defense (DoD), specifically the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract, valued at $101,771.28, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with no set-aside designation, issued under DMS Pharmaceutical Group's...
This is a federal contract award from the Department of Veterans Affairs (VA) to Astellas Pharma US, Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract is a delivery order under the VA's Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB), with a firm fixed price of $108,180.00 and a period of performance ending on January 31, 2018. The contract is for the supply of LEXISCAN SYRINGE PREFILLED, a pharmaceutical product, with no set-aside designation. Astellas Pharma US,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,245.40 contract is for the delivery of 120 capsules of the prescription drug XTANDI 40 MG. The award is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which provides for the supply of a comprehensive range of pharmaceutical...